These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18026137)

  • 1. A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
    Banerjee T; Duhadaway JB; Gaspari P; Sutanto-Ward E; Munn DH; Mellor AL; Malachowski WP; Prendergast GC; Muller AJ
    Oncogene; 2008 May; 27(20):2851-7. PubMed ID: 18026137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.
    Muller AJ; DuHadaway JB; Donover PS; Sutanto-Ward E; Prendergast GC
    Nat Med; 2005 Mar; 11(3):312-9. PubMed ID: 15711557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.
    Gaspari P; Banerjee T; Malachowski WP; Muller AJ; Prendergast GC; DuHadaway J; Bennett S; Donovan AM
    J Med Chem; 2006 Jan; 49(2):684-92. PubMed ID: 16420054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
    Yoshida N; Ino K; Ishida Y; Kajiyama H; Yamamoto E; Shibata K; Terauchi M; Nawa A; Akimoto H; Takikawa O; Isobe K; Kikkawa F
    Clin Cancer Res; 2008 Nov; 14(22):7251-9. PubMed ID: 19010841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
    Hou DY; Muller AJ; Sharma MD; DuHadaway J; Banerjee T; Johnson M; Mellor AL; Prendergast GC; Munn DH
    Cancer Res; 2007 Jan; 67(2):792-801. PubMed ID: 17234791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Dolušić E; Larrieu P; Blanc S; Sapunaric F; Norberg B; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
    Bioorg Med Chem; 2011 Feb; 19(4):1550-61. PubMed ID: 21269836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrying immunotherapy with chemotherapy: why say IDO?
    Muller AJ; Prendergast GC
    Cancer Res; 2005 Sep; 65(18):8065-8. PubMed ID: 16166276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
    Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
    J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression.
    Liu H; Liu L; Liu K; Bizargity P; Hancock WW; Visner GA
    J Immunol; 2009 Jul; 183(2):1022-31. PubMed ID: 19564344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.
    Jung ID; Lee MG; Chang JH; Lee JS; Jeong YI; Lee CM; Park WS; Han J; Seo SK; Lee SY; Park YM
    J Immunol; 2009 Mar; 182(5):3146-54. PubMed ID: 19234212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation.
    Munn DH
    Curr Opin Immunol; 2006 Apr; 18(2):220-5. PubMed ID: 16460921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.
    Muller AJ; DuHadaway JB; Jaller D; Curtis P; Metz R; Prendergast GC
    Cancer Res; 2010 Mar; 70(5):1845-53. PubMed ID: 20160032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isosteric probes provide structural requirements essential for detoxification of the phytoalexin brassinin by the fungal pathogen Leptosphaeria maculans.
    Pedras MS; Jha M; Minic Z; Okeola OG
    Bioorg Med Chem; 2007 Sep; 15(18):6054-61. PubMed ID: 17616463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.
    Vottero E; Balgi A; Woods K; Tugendreich S; Melese T; Andersen RJ; Mauk AG; Roberge M
    Biotechnol J; 2006 Mar; 1(3):282-8. PubMed ID: 16897708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated rejection of the second transplants of immunogenic tumor in mice under inhibition of indoleamine 2,3-dioxygenase activity by ethyl pyruvate.
    Vasilyeva ED; Kaledin V; Nikolin VP; Popova NA; Kirilyuk IA; Grigor'ev IA
    Exp Oncol; 2012; 34(1):66-8. PubMed ID: 22453153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isobrassinin and its analogues: novel types of antiproliferative agents.
    Csomós P; Zupkó I; Réthy B; Fodor L; Falkay G; Bernáth G
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6273-6. PubMed ID: 16997552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
    Dolusić E; Larrieu P; Moineaux L; Stroobant V; Pilotte L; Colau D; Pochet L; Van den Eynde B; Masereel B; Wouters J; Frédérick R
    J Med Chem; 2011 Aug; 54(15):5320-34. PubMed ID: 21726069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
    Yang S; Li X; Hu F; Li Y; Yang Y; Yan J; Kuang C; Yang Q
    J Med Chem; 2013 Nov; 56(21):8321-31. PubMed ID: 24099220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.